Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival
Abstract Background For early‐stage non‐small cell lung cancer (NSCLC), surgical resection is considered the most effective treatment strategy and curative treatment. Unfortunately, even after complete resection, almost half of all patients with stage I–IIIA NSCLC relapse and die. Although the possi...
Main Authors: | Hisao Imai, Ryoichi Onozato, Kyoichi Kaira, Sayaka Kawashima, Ken Masubuchi, Toshiteru Nagashima, Kohei Tajima, Koichi Minato |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14119 |
Similar Items
-
Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing <i>EGFR</i> Mutations
by: Hisao Imai, et al.
Published: (2021-05-01) -
Clinical impact of post-progression survival in patients with locally advanced non-small cell lung cancer after chemoradiotherapy
by: Imai Hisao, et al.
Published: (2022-02-01) -
Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival
by: Ken Masubuchi, et al.
Published: (2022-10-01) -
Post‐progression survival is highly linked to overall survival in patients with non‐small‐cell lung cancer harboring sensitive EGFR mutations treated with first‐line epidermal growth factor receptor‐tyrosine kinase inhibitors
by: Hisao Imai, et al.
Published: (2019-12-01) -
Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma
by: Mingkun Zhao, et al.
Published: (2022-12-01)